Prat A, Tsai YH, Pascual T, Pare L, et al. A prognostic model based on PAM50 and clinical variables (PAM50MET) for metastatic hormone-receptor-positive HER2-negative breast cancer. Clin Cancer Res 2020 Sep 22. pii: 1078-0432.CCR-20-2793.
PMID: 32962980